Interaction of apolipoprotein E ε 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: Problems facing the investigator

Neurochemical Research

Volumn 23, Issue 3, 1998, Pages 369-376

  Katzman, R ^a,b   Kang, D ^a   Thomas, R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alleles, 1 antichymotrypsin, VLDLR, multiple comparisons; Alzheimer disease; Apolipoprotein E; Genetic risk factors

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID PROTEIN; APOLIPOPROTEIN E4; LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; GENE FREQUENCY; GENETIC VARIABILITY; HEAD INJURY; HUMAN; ONSET AGE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; HUMANS; RISK FACTORS;

EID: 0031936512     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022461601609     Document Type: Review

References (83)

1. Thudicum, J. L. W. 1885. A Treatise on the Chemical Constitution of the Brain. Reprinted in 1962 by Archon books, Hamden, Connecticut.
2. Autilio, L. A., Norton, W. T., and Terry, R. D. 1963. The preparation and some properties of purified myelin from the central nervous system. J. Neurochem. 20:733-738.
3. Norton, W. T., and Poduslo, S. E. 1970. Neuronal soma and whole neuroglia of rate brain: A new isolation technique. Science 167:1144-1146.
4. Raine, C. S., Poduslo, S. E., and Norton, W. T. 1971. The ultrastrucrure of purified preparations of neurons and glial cells. Brain Res. 27:11-24.
5. Goate, A., Chartier-Harlin, M. C., Mullan, M., et al 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
6. Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. 1991. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 254:97-99.
7. Sherrington, R., Rogaev, E. I., Liang, Y., et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375:754-760.
8. Levy-Lahad, E., Wasco, W., Poorkaj, P. et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus [see comments]. Science, 269:973-7.
9. Younkin, S. G. 1995. Evidence that A beta 42 is the real culprit in Alzheimer's disease Ann Neurol 37:287-8.
10. Jorm, A. F., A. E. Körten, and Henderson, A. S. 1987. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr. Scand. 76:464-479.
11. Corder, E. H., A. M. Saunders, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
12. Lucotte, G., S. Visvikis, et al. 1994. Association of Apolipoprotein E allele E4 with late onset sporadic Alzheimer's disease. Am. J. of Med. Genet. 54:286-288.
13. Zannis, V. I., and J. L. Breslow 1981. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 20:1033-1041.
14. Eichner, J. E., L. H. Kuller, et al. 1993. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Amer. J. of Cardiology 71:160-165.
15. Yamamura, T., L. M. Dong, et al. 1992. Apolipoprotein E polymorphism and coronary heart disease. Chinese Med. J. 105:738-741.
16. Menzel, H. J., R. G. Kladetzky, and Assman, G. 1983. Apolipoprotein E polymorphism and coronary artery disease Arteriosclerosis 3:310-315.
17. Utermann, G., U. Steinmetz, A., and Weber, W. 1982. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. Am. J. Hum. Genet. 32:339-347.
18. Hallman, D. M., Boerwinkle, E., Saha, N., Sandholzer, C. et al. 1991. The Apolipoprotein E Polymorphism: a Comparison of Allele Frequencies and Effects in Nine Populations. Am. J. Human. Genet. 1991; 49:338-349.
19. Gerdes, L. U., I. C. Klausen, Sihm, I., and Faergeman, O. 1992. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genetic Epidemiology 9:155-167.
20. Eggertsen, G., Tegelman, R., Ericsson, S., et al. 1993. Apolipoprotein E Polymorphism in a Healthy Swedish Population: Variation of Allele Frequency with Age and Relation to Serum Lipid Concentrations. Clin. Chem. 39:2125-2129.
21. James, R. W., Boemi, M., Giansanti, R., et al. 1993. Underexpression of the apolipoprotein E4 isoform in an Italian population. Aterioscler Thromb 13:1456-1459
22. Cariolou, M. A., Kokkofitou, A., Manoli, P. et al. 1995. Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus. Genet. Epidemiol. 12:489-97.
23. Pericak-Vance, M. A., Johnson, C. C., Rimmler, J. B. et al. 1996. Alzheimer disease and apolipoprotein E-4 allele in an Amish population. Ann. Neurol. 39:700-704.
24. Kamboh, M. I., Bhatia, K. K., and Ferrell, R. E. 1990. Genetic studies of human apoproteins. XII. Population genetics of apolipoprotein polymorphisms in Papua New Guinea. Am. J. Hum. Biol. 2:17-23.
25. Osuntokun, B. O., Sahota, A., Ogunniyi, A. O., et al. 1995. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Annals of Neurology; 38:463-5.
26. Mayeux, R., Stern, Y., Ottman, R. et al. 1993. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:752-754.
27. Hendrie, H. C., Hall, K. S., Hui, S. et al. 1995. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann. of Neurol. 37:118-20
28. Katzman, R., Zhang, M-Y., Chen, P. J., Gu, N. et al. Effects of Apolipoprotein E on Dementia and Aging in the Shanghai Survey of Dementia. Neurology. In Press.
29. Kao, J. T., Tsai, K. S., Chang, C. J., and Huang, P. C. 1995. The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 114:55-59
30. Mahley, R. W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
31. Christie, R. H., Chung, H., Rebeck, G. W., Strickland, D., and Hyman, B. T. 1996. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J. Neuropath. Exp. Neur. 55:491-8
32. Kounnas, M. Z., Moir, R. D., Rebeck, G. W. et al., 1995. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82:331-40.
33. Kim, D. H., Iijima, H., Goto, K. et al. 1996 Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. Journal of Biological Chemistry. 271:8373-80.
34. Pitas, R. E., J. K. Boyles, Lee, S. H., Foss, D., and Mahley, R. W. 1987. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917:148-161.
35. Wisniewski, T., and B. Frangione 1992. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:235-238.
36. Pericak-Vance, M. A., Bebout, J. L., Gaskell, P. C. Jr, et al. 1991. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48:1034-1050.
37. Weeks, D. E., and Lange, K. 1988. The affected-pedigree-member method of linkage analysis. Am. J. of Hum. Genet. 1988 42:315-26.
38. Strittmatter, W. J., Saunders, A. M., Schmechel, D. et al. 1993. Apolipoprotein E: High avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1977-1981.
39. Rebeck, G. W., Reiter, J. S., Strickland, D. K., and Hyman, B. T. 1993 Apolipoprotein E in Alzheimer's Disease: Allelic Variation and Receptor Interactions. Neuron 11:575-580
40. Galasko, D., Saitoh, T., Xia, Y. et al. 1994. The apolipoprotein E allele e4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44:1950-1951.
41. Bickeboller, H., D. Campion, et al. (1997). "Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex." Am. J. Hum. Genet. 60(2):439-446.
42. Brousseau, T., Legrain, S., Berr, C. et al. 1994. Confirmation of the e4 Allele of the Apolipoprotein E Gene as a Risk Factor for Late-Onset Alzheimer's Disease. Neurology 44:342-344.
43. Mayeux, R., Stern, Y., Ottman, R. et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 1993; 34:752-754.
44. Saunders, A. M., Strittmatter, W. J., Schmechel, D. et al. 1993. Association of Apolipoprotein E Allele e4 with Late-Onset Familial and Sporadic Alzheimer's Disease. Neurology 43:1467-1472
45. Myers, R. H., Schaefer, E. J., Wilson, P. W. et al. 1996. Apolipoprotein E epsilon4 association with dementia in a populationbased study: The Framingham study. Neurology 46:673-7.
46. Tsuang, D., Kukull, W., Sheppard, L. et al. 1996. Impact of sample selection on APOEe4 allele frequency: a comparison of two Alzheimer's disease samples. J. Am. Geriatr. Soc. 44:704-707
47. Kuusisto, J., K. Koivisto, et al. 1994. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 309:636-8.
48. Pirttila, T., Lehtimaki, T., Nikkari, T. et al. 1995. Apolipoprotein E E4 allele and risk of dementia. JAMA. 273:375-6.
49. Ueki, A., Kawano, M., Namba, Y. et al. 1993. A High frequency of apolipoprotein e4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:166-168.
50. Noguchi, S., Murakami, K., and Yamada, N. 1993. Apolipoprotein E genotype and Alzheimer's disease. Lancet 342:737
51. Sakoda, S., Kuriyama, M., Osame, M. et al. 1994. Apolipoprotein E epsilon 4. Neurology. 44:2420.
52. Kalzman, R., Zhang, M.-Y., P. J. Chen, M. D. et al. 1997. Effects of Apolipoprotein E on Dementia and Aging in the Shanghai Survey of Dementia. Neurology: In Press.
53. Mak, Y., H. Chiu, Woo, J. et al. 1996. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 46:146-149.
54. Osuntokun, B. O., Sahota, A., Ogunniyi, A. O. et al. 1995 Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 38:463-5
55. Schmechel, D. E., Saunders, A. M., Strittmatter, et al. 1993. Increased amyloid β-peptide deposition as a consequence of apolipoprotein ε genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:9649-9653
56. Hyman, B. T., Gomez-Isla, T., West, H., Briggs, M., Chung, H., Growdon, J. H., and Rebeck, G. W. 1996. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Ann. N. Y. Acad. Sci. 777:158-65.
57. Olichney, J. M., Hansen, L. A., Galasko, et al. The apolipoprotein E e4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy Body Variant. Neurology. 1996; 47:1-7
58. Metzger, R. E., LaDu, M. J., Pan, J. B., Getz, G. S., Frail, D. E., and Falduto, M. T. 1996. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:372-80.
59. Fleming, L. M., Weisgraber, K. H., Strittmatter, W. J., Troncoso, J. C., and Johnson, G. V. 1996. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp. Neurol. 138:252-60.
60. Rebeck, W., J. H. Growdon, and Hyman, B. T. 1994. Apolipoprotein E4 affects neuropathology but not clinical progression in Alzheimer's disease. Neurobiology of Aging 15:828.
61. Nagy, Z., Esiri, M. M., Jobst, K. A., Johnston, C. et al. 1995. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease Neuroscience, 1995, 69:757-61.
62. Heyman, A., Wilkinson, W. E., Stafford, J. A., et al. 1984. Alzheimer's disease: A study of epidemiological aspects. Ann. Neurol. 15:335-341.
63. Mortimer, J. A., van Duijn, C. M., Chandra, V. et al. 1991. Head trauma as a risk factor for Alzheimer's disease: A collaborative reanalysis of case-control studies. Int. J. Epidemiol., 20(Suppl 2):S28-35.
64. Roberts, G. W., Allsop, D., and Bruton, C. 1990. The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry. 53:273-278.
65. Clinton, J., Ambler, M. W., and Roberts, G. W. 1991. Post-traumatic Alzheimer's disease: preponderance of a single plaque type. Neuropathol. Appl. Neurobiol. 17:69-74.
66. Nicoll, J. A., Roberts, G. W., and Graham, D. I. 1996. Amyloid beta-protein, APOE genotype and head injury. Ann. N. Y. Acad. Sci. 777:271-5.
67. Mayeux, R., Ottman, R., Maeslre, G., el al. 1995. Synergistic effects of traumatic head injury and apolipoprolein-epsilon 4 in patienls with Alzheimer's disease. Neurology. 45:555-557.
68. Katzman, R., Galasko, D. R., Saitoh, T., et al. 1996. Apotipoprotein-epsilon4 and head trauma: Synergistic or additive risks? [letter]. Neurology. 46:889-891.
69. Abraham, C. R., Selkoe, D. J., and Potter, H. 1988. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:487-501.
70. Kamboh, M. I., Sanghera, D. K., Ferrell, R. E., and DeKosky, S. T. 1995. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat. Genet. 10:486-8.
71. Haines, J. L., Pritchard, M. L., Saunders, A. M., et al. 1996. No genetic effect of alpha 1-antichymotrypsin in Alzheimer disease. Genomics, 1996; 33:53-6.
72. Wright, S. P., Adjusted P-Values for Simultaneous Inference. 1992. Biometrics 48:1005-1013.
73. Holm, S. A simple sequentially rejective multiple trial procedure, 1979. Scand J of Statistics, 6:65-70
74. Xia, Y., Rohan de Silva, H. A., Rosi, B. L., et al. 1996 Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism. Annals, of Neurology 1996; 40:207-215.
75. Okuizumi, K., O. Onodera, Namba, Y., et al. 1995. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat. Genet. 11(2):207-9.
76. Okuizumi, K., Onodera, O., Seki, K., Tanaka, H., et al. 1996. Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann. of Neurol. 40:251-4.
77. Chung, H., Roberts, C. T., Greenberg, S., Rebeck, G. W., Christie, R., Wallace, R., Jacob, H. J., and Hyman, B. T. 1996. Lack of association of trinucleotide repeat polymorphisms in very-low-density lipoprotein receptor gene with Alzheimer's disease. Ann. of Neurol. 39:800-803.
78. Rang, D. E., Saitoh, T., Chen, X., et al. 1997. Genetic Evidence for the involvement of the low density lipoprotein receptor related protein (LRP), and ApoE receptor, in late-onset Alzheimer's Disease. Neurology 49:56-61.
79. Perez-Tur, J., Froelich, S., Prihar, et al. 1995. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport. 7:297-301.
80. Owen, M. J., Kehoe, P., and Williams, J. 1996. Presenilin-1 polymorphism and Alzheimer's disease [letter]. Lancet. 348:414.
81. Higuchi, S., Muramatsu, T., Matsushita, S., Arai, H., and Sasaki, H. 1996. Presenilin-1 polymorphism and Alzheimer's disease [letter]. Lancet. 347:1186.
82. Scott, W. K., Growdon, J. H., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. 1996. Presenilin-1 polymorphism and Alzheimer's disease [letter]. Lancet, 347:1186-7.
83. Perez-Tur, J., Wavrant-De Vrieze, F., Lambert, J. C., and Chartier-Harlin, M. C. 1996. Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group [letter]. Lancet. 347:1560-1.